• #40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant

  • May 29 2024
  • Length: 18 mins
  • Podcast

#40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant

Listen for free

View show details

  • Summary

  • Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.

    What you'll get out of this episode:

    • Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.
    • Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.
    • The need for diverse site participation and data inputs to improve trial accuracy and efficiency.
    • The role of AI and technology in enhancing clinical trial processes.


    To learn more about our guests and their companies:
    Christine's LinkedIn https://www.linkedin.com/in/christinesenn/
    Rohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/

    Advarra LinkedIn https://www.linkedin.com/company/advarra/
    Lokavant LinkedIn https://www.linkedin.com/company/lokavant/

    Advarra Website https://www.advarra.com/
    Lokavant Website https://www.lokavant.com/en-us/

    Our sponsor for this episode is:
    Sage Growth Partners https://sage-growth.com/

    BioBreakthroughs is part of the Slice of Healthcare podcast network:
    LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about #40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available